All News

Recent advancements in treatment options for patients with diffuse large B-cell lymphoma have been practice-changing.

The TROPION-Lung04 trial reveals improvements from combining Dato-DXd with Imfinzi with or without carboplatin for patients with previously untreated advanced or metastatic non-small cell lung cancer (NSCLC) without actionable genomic alterations.

Treatments intended to reduce biochemical recurrence in patients with prostate cancer may not improve long-term survival, recent research showed.

Researchers have found alternatives to opioid pills, which reduces the risk of misuse and addiction in patients undergoing pancreatic cancer surgery.

Recent developments in PARP inhibitor combinations and antibody-drug-conjugates are changing the landscape of ovarian cancer treatment.

“And… ok, that’s enough!” That was my brain’s reaction after the oncologist broke the news.

The recent FDA approval of Lonsurf plus Avastin for metastatic colorectal cancer improves survival and quality of life, an expert said.

The phase 2 ARROS-1 trial will investigate NVL-520 in patients with pretreated ROS1-positive non-small cell lung cancer or other solid tumors.

While PET scans have been used to predict Hodgkin lymphoma outcomes, adding Adcetris to frontline therapy improved outcomes for patients, regardless of their results.

I don’t know about you, but music moves me. Literally. It makes me move.

The FDA has approved Aphexda plus filgrastim for the mobilization of hematopoietic stem cells in patients with multiple myeloma.

Patients with acute myeloid leukemia who took vitamin C and D supplements experienced fewer complications, but no overall survival benefits.

The phase 3 MARIPOSA- 2 study shows significant improvement within progression free survival after implementing Rybrevant into treatment for patients with non-small cell lung cancer.

Iclusig plust reduced-intensity bested Gleevec when it came to MRD-negative complete remission in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.

Before my biopsy, the doctor assured me it was nothing. He said he was just doing this to prove it to me. We definitely didn’t expect what followed next.

Elderly patients with acute myeloid leukemia did not experience a difference in relapse-free survival or non-relapse mortality with intensive versus non-intensive chemotherapy.

Survival outcomes and disparities for patients with blood cancers may depend on factors including insurance coverage, economic status and marital status.

"Margaritaville" singer-songwriter Jimmy Buffett died four years after receiving a diagnosis of Merkel cell carcinoma that "can be really nasty," one expert tells CURE.

After getting over the shock of being diagnosed with a rare cancer, I could only think about returning to my “normal” self, but I later discovered that the normal I was trying to return to would change.

As Linda Evangelists announces second cancer diagnosis and a new artificial intelligence tool identifies cancer diagnoses, this is what’s happening in the oncology space this week.

Myelofibrosis-related anemia is different than anemia experienced by patients without a cancer diagnosis, a research nurse explained.

Vitamin D supplements have been shown to reduce the risk of relapse or death in patients with digestive tract cancer.

Varying outcomes among adolescent and young adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia treated with pediatric-inspired protocols or adult chemotherapy regimens warrant further study.

The Food and Drug Administration, in a flurry of activity, approved three new medications across a three-month period earlier this year.

I like to think that I always checked off the “be an organ donor” box on my driver’s license forms, but of course that just may be the way I remember it.

"I’m on a healthy footing, and that’s pretty miraculous," said singer-songwriter Andrew McMahon, an acute lymphoblastic leukemia survivor and founder of the Dear Jack Foundation.

An expert explained the benefits of proton therapy for the treatment of prostate cancer, which delivers radiation directly to the tumor and spares surrounding areas.

MRD testing began among patients with chronic myeloid leukemia, a disease that lends itself to gauging MRD because it is driven by a specific genetic mutation.